These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 7526003)

  • 21. Serum BPSA outperforms both total PSA and free PSA as a predictor of prostatic enlargement in men without prostate cancer.
    Canto EI; Singh H; Shariat SF; Lamb DJ; Mikolajczyk SD; Linton HJ; Rittenhouse HG; Kadmon D; Miles BJ; Slawin KM
    Urology; 2004 May; 63(5):905-10; discussion 910-1. PubMed ID: 15134977
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The value of percent free prostate specific antigen, prostate specific antigen density of the whole prostate and of the transition zone in Turkish men.
    Akduman B; Alkibay T; Tuncel A; Bozkirli I
    Can J Urol; 2000 Oct; 7(5):1104-9. PubMed ID: 11114873
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of dutasteride on the peripheral and transition zones of the prostate and the value of the transition zone index in predicting treatment response.
    Marks LS; Roehrborn CG; Wolford E; Wilson TH
    J Urol; 2007 Apr; 177(4):1408-13. PubMed ID: 17382742
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Calculated fast-growing benign prostatic hyperplasia--a risk factor for developing clinical prostate cancer.
    Hammarsten J; Högstedt B
    Scand J Urol Nephrol; 2002; 36(5):330-8. PubMed ID: 12487736
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Predictive value of prostate specific antigen density in the detection of prostate cancer in patients with elevated prostate specific antigen levels and normal digital rectal findings or stage A prostate cancer].
    Iwaki H; Kajita Y; Shimizu Y; Yamauchi T
    Hinyokika Kiyo; 2001 Mar; 47(3):169-74. PubMed ID: 11329957
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pathological parameters of radical prostatectomy for clinical stages T1c versus T2 prostate adenocarcinoma: decreased pathological stage and increased detection of transition zone tumors.
    Jack GS; Cookson MS; Coffey CS; Vader V; Roberts RL; Chang SS; Smith JA; Shappell SB
    J Urol; 2002 Aug; 168(2):519-24. PubMed ID: 12131301
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The role of prostate specific antigen in diagnosis of localized adenocarcinoma of the prostate. Nara Uro-Oncology Research Group].
    Hirao Y; Ozono S; Kagebayashi Y; Yoshi M; Tani Y; Uemura H; Momose H; Okajima E
    Hinyokika Kiyo; 1996 Oct; 42(10):795-804. PubMed ID: 8951478
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationship between serum prostate-specific antigen and prostate volume in Korean men with benign prostatic hyperplasia: a multicentre study.
    Chung BH; Hong SJ; Cho JS; Seong DH
    BJU Int; 2006 Apr; 97(4):742-6. PubMed ID: 16536765
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prostate specific antigen density of the transition zone: a new effective parameter for prostate cancer prediction.
    Zlotta AR; Djavan B; Marberger M; Schulman CC
    J Urol; 1997 Apr; 157(4):1315-21. PubMed ID: 9120930
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhanced expression of prostate-specific antigen in the transition zone of the prostate. A characterization following prostatectomy for benign hyperplasia.
    Recker F; Kwiatkowski MK; Pettersson K; Piironen T; Lümmen G; Huber A; Tscholl R
    Eur Urol; 1998; 33(6):549-55. PubMed ID: 9743696
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changes in serum prostate-specific antigen following prostatectomy in patients with benign prostate hyperplasia.
    Furuya Y; Akakura K; Tobe T; Ichikawa T; Igarashi T; Ito H
    Int J Urol; 2000 Dec; 7(12):447-51. PubMed ID: 11168683
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Percent of free serum prostate-specific antigen and histological findings in patients undergoing open prostatectomy for benign prostatic hyperplasia.
    Scattoni V; Raber M; Montorsi F; Da Pozzo L; Brausi M; Calori G; Freschi M; Rigatti P
    Eur Urol; 1999 Dec; 36(6):621-30. PubMed ID: 10559617
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A retrospective study: correlation of histologic inflammation in biopsy specimens of Chinese men undergoing surgery for benign prostatic hyperplasia with serum prostate-specific antigen.
    Song L; Zhu Y; Han P; Chen N; Lin D; Lai J; Wei Q
    Urology; 2011 Mar; 77(3):688-92. PubMed ID: 20974483
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of the transition zone for elevating serum prostate-specific antigen in benign prostatic hyperplasia.
    Sakamoto W; Iwata H; Kamikawa S; Tsurusaki K; Sugimoto T; Nakatani T; Sugimura K; Yamamoto K; Kishimoto T
    Int J Urol; 1998 Mar; 5(2):163-6. PubMed ID: 9559843
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship between serum prostate-specific antigen and calculated epithelial volume.
    Fukatsu A; Ono Y; Ito M; Yoshino Y; Hattori R; Gotoh M; Ohshima S
    Urology; 2003 Feb; 61(2):370-4. PubMed ID: 12597950
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prostate-specific antigen levels and density in the internal and external glands of the prostate in benign prostatic hyperplasia patients with normal or gray-zone PSA levels.
    Zuo W; Hiraoka Y
    Urol Int; 2003; 71(2):154-9. PubMed ID: 12890952
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of prostate-specific antigen corrected for total prostate volume and transition zone volume in a population-based screening study.
    Rietbergen JB; Kranse R; Hoedemaeker RF; Kruger AE; Bangma CH; Kirkels WJ; Schröder FH
    Urology; 1998 Aug; 52(2):237-46. PubMed ID: 9697788
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predicted and actual change in serum PSA following prostatectomy for BPH.
    Lloyd SN; Collins GN; McKelvie GB; Hehir M; Rogers AC
    Urology; 1994 Apr; 43(4):472-9. PubMed ID: 7512298
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Standardized assessment to enhance the diagnostic value of prostate volume; Part II: Correlation with prostate-specific antigen levels.
    Aarnink RG; de la Rosette JJ; Huynen AL; Giesen RJ; Debruyne FM; Wijkstra H
    Prostate; 1996 Nov; 29(5):327-33. PubMed ID: 8899006
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Contribution of genetic variation rs266882 to prostate-specific antigen levels in healthy controls with serum PSA below 2.0 ng/ml.
    Song J; Park H; Lee G
    Biochem Genet; 2013 Apr; 51(3-4):264-74. PubMed ID: 23315126
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.